A comprehensive appraisal on Crocus chrysanthus (Herb.) Herb. flower extracts with HPLC–MS/MS profiles, antioxidant and enzyme inhibitory properties

Gokhan Zengin, Muhammad Zakariyyah Aumeeruddy, Alina Diuzheva, J. Jekó́, Zoltán Cziáky, Aysegul Yıldıztugay, Evren Yıldıztugay, Mohamad Fawzi Mahomoodally

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In the quest for new drugs of herbal origin, the ethyl acetate (EAE), methanol (ME), and water (WE) extracts of Crocus chrysanthus (Herb.) Herb. flowers were analyzed for their polyphenolic composition, antioxidant, and enzyme inhibitory potential. WE showed the highest antioxidant activities in all assays including metal chelating, phosphomolybdenum, FRAP, CUPRAC, ABTS and DPPH. EAE was the most effective enzyme inhibitor, exhibiting the highest inhibition against some enzymes linked to Alzheimer's disease (cholinesterases), diabetes mellitus (α-glucosidase and α-amylase) and hyperpigmentation problems (tyrosinase). The highest total phenolics (34.99 mg GAE/g) and flavonoids content (77.58 mg RE/g) were observed in WE and ME, respectively. Eight compounds were identified in EAE, 24 in ME, and 15 in WE. Kaempferol 3-O glucoside was found in all extracts. In conclusion, C. chrysanthus flowers can be suggested as a source of bioactive components with potential use against chronic disorders caused by oxidative stress. Future in-depth studies are recommended to determine the biological effects of isolated compounds from C. chrysanthus to identify the main compounds modulating the observed activities.

Original languageEnglish
Pages (from-to)581-589
Number of pages9
JournalJournal of Pharmaceutical and Biomedical Analysis
Volume164
DOIs
Publication statusPublished - Feb 5 2019

Fingerprint

Antioxidants
Methanol
Water
Enzymes
Glucosidases
Hyperpigmentation
Oxidative stress
Monophenol Monooxygenase
Cholinesterases
Enzyme Inhibitors
Amylases
Medical problems
Chelation
Flavonoids
Assays
Diabetes Mellitus
Alzheimer Disease
Oxidative Stress
Metals
Chemical analysis

Keywords

  • Crocus chrysanthus
  • Enzyme inhibitor
  • Oxidative stress
  • Polyphenolic

ASJC Scopus subject areas

  • Analytical Chemistry
  • Pharmaceutical Science
  • Drug Discovery
  • Spectroscopy
  • Clinical Biochemistry

Cite this

A comprehensive appraisal on Crocus chrysanthus (Herb.) Herb. flower extracts with HPLC–MS/MS profiles, antioxidant and enzyme inhibitory properties. / Zengin, Gokhan; Aumeeruddy, Muhammad Zakariyyah; Diuzheva, Alina; Jekó́, J.; Cziáky, Zoltán; Yıldıztugay, Aysegul; Yıldıztugay, Evren; Mahomoodally, Mohamad Fawzi.

In: Journal of Pharmaceutical and Biomedical Analysis, Vol. 164, 05.02.2019, p. 581-589.

Research output: Contribution to journalArticle

Zengin, Gokhan ; Aumeeruddy, Muhammad Zakariyyah ; Diuzheva, Alina ; Jekó́, J. ; Cziáky, Zoltán ; Yıldıztugay, Aysegul ; Yıldıztugay, Evren ; Mahomoodally, Mohamad Fawzi. / A comprehensive appraisal on Crocus chrysanthus (Herb.) Herb. flower extracts with HPLC–MS/MS profiles, antioxidant and enzyme inhibitory properties. In: Journal of Pharmaceutical and Biomedical Analysis. 2019 ; Vol. 164. pp. 581-589.
@article{45356ef2973e43ce8c6a2335b72868bc,
title = "A comprehensive appraisal on Crocus chrysanthus (Herb.) Herb. flower extracts with HPLC–MS/MS profiles, antioxidant and enzyme inhibitory properties",
abstract = "In the quest for new drugs of herbal origin, the ethyl acetate (EAE), methanol (ME), and water (WE) extracts of Crocus chrysanthus (Herb.) Herb. flowers were analyzed for their polyphenolic composition, antioxidant, and enzyme inhibitory potential. WE showed the highest antioxidant activities in all assays including metal chelating, phosphomolybdenum, FRAP, CUPRAC, ABTS and DPPH. EAE was the most effective enzyme inhibitor, exhibiting the highest inhibition against some enzymes linked to Alzheimer's disease (cholinesterases), diabetes mellitus (α-glucosidase and α-amylase) and hyperpigmentation problems (tyrosinase). The highest total phenolics (34.99 mg GAE/g) and flavonoids content (77.58 mg RE/g) were observed in WE and ME, respectively. Eight compounds were identified in EAE, 24 in ME, and 15 in WE. Kaempferol 3-O glucoside was found in all extracts. In conclusion, C. chrysanthus flowers can be suggested as a source of bioactive components with potential use against chronic disorders caused by oxidative stress. Future in-depth studies are recommended to determine the biological effects of isolated compounds from C. chrysanthus to identify the main compounds modulating the observed activities.",
keywords = "Crocus chrysanthus, Enzyme inhibitor, Oxidative stress, Polyphenolic",
author = "Gokhan Zengin and Aumeeruddy, {Muhammad Zakariyyah} and Alina Diuzheva and J. Jek{\'o}́ and Zolt{\'a}n Czi{\'a}ky and Aysegul Yıldıztugay and Evren Yıldıztugay and Mahomoodally, {Mohamad Fawzi}",
year = "2019",
month = "2",
day = "5",
doi = "10.1016/j.jpba.2018.11.022",
language = "English",
volume = "164",
pages = "581--589",
journal = "Journal of Pharmaceutical and Biomedical Analysis",
issn = "0731-7085",
publisher = "Elsevier",

}

TY - JOUR

T1 - A comprehensive appraisal on Crocus chrysanthus (Herb.) Herb. flower extracts with HPLC–MS/MS profiles, antioxidant and enzyme inhibitory properties

AU - Zengin, Gokhan

AU - Aumeeruddy, Muhammad Zakariyyah

AU - Diuzheva, Alina

AU - Jekó́, J.

AU - Cziáky, Zoltán

AU - Yıldıztugay, Aysegul

AU - Yıldıztugay, Evren

AU - Mahomoodally, Mohamad Fawzi

PY - 2019/2/5

Y1 - 2019/2/5

N2 - In the quest for new drugs of herbal origin, the ethyl acetate (EAE), methanol (ME), and water (WE) extracts of Crocus chrysanthus (Herb.) Herb. flowers were analyzed for their polyphenolic composition, antioxidant, and enzyme inhibitory potential. WE showed the highest antioxidant activities in all assays including metal chelating, phosphomolybdenum, FRAP, CUPRAC, ABTS and DPPH. EAE was the most effective enzyme inhibitor, exhibiting the highest inhibition against some enzymes linked to Alzheimer's disease (cholinesterases), diabetes mellitus (α-glucosidase and α-amylase) and hyperpigmentation problems (tyrosinase). The highest total phenolics (34.99 mg GAE/g) and flavonoids content (77.58 mg RE/g) were observed in WE and ME, respectively. Eight compounds were identified in EAE, 24 in ME, and 15 in WE. Kaempferol 3-O glucoside was found in all extracts. In conclusion, C. chrysanthus flowers can be suggested as a source of bioactive components with potential use against chronic disorders caused by oxidative stress. Future in-depth studies are recommended to determine the biological effects of isolated compounds from C. chrysanthus to identify the main compounds modulating the observed activities.

AB - In the quest for new drugs of herbal origin, the ethyl acetate (EAE), methanol (ME), and water (WE) extracts of Crocus chrysanthus (Herb.) Herb. flowers were analyzed for their polyphenolic composition, antioxidant, and enzyme inhibitory potential. WE showed the highest antioxidant activities in all assays including metal chelating, phosphomolybdenum, FRAP, CUPRAC, ABTS and DPPH. EAE was the most effective enzyme inhibitor, exhibiting the highest inhibition against some enzymes linked to Alzheimer's disease (cholinesterases), diabetes mellitus (α-glucosidase and α-amylase) and hyperpigmentation problems (tyrosinase). The highest total phenolics (34.99 mg GAE/g) and flavonoids content (77.58 mg RE/g) were observed in WE and ME, respectively. Eight compounds were identified in EAE, 24 in ME, and 15 in WE. Kaempferol 3-O glucoside was found in all extracts. In conclusion, C. chrysanthus flowers can be suggested as a source of bioactive components with potential use against chronic disorders caused by oxidative stress. Future in-depth studies are recommended to determine the biological effects of isolated compounds from C. chrysanthus to identify the main compounds modulating the observed activities.

KW - Crocus chrysanthus

KW - Enzyme inhibitor

KW - Oxidative stress

KW - Polyphenolic

UR - http://www.scopus.com/inward/record.url?scp=85056733063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056733063&partnerID=8YFLogxK

U2 - 10.1016/j.jpba.2018.11.022

DO - 10.1016/j.jpba.2018.11.022

M3 - Article

C2 - 30466026

AN - SCOPUS:85056733063

VL - 164

SP - 581

EP - 589

JO - Journal of Pharmaceutical and Biomedical Analysis

JF - Journal of Pharmaceutical and Biomedical Analysis

SN - 0731-7085

ER -